DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.83%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.99B
AUM Growth
+$2.99B
(-2.3%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-8.2%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
154
New
30
Increased
26
Reduced
34
Closed
30
Top Buys
| 1 |
Viatris
VTRS
|
$58.4M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$56.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$35.8M |
| 5 |
Galapagos
GLPG
|
$33.1M |
Top Sells
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$446M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
Adverum Biotechnologies
ADVM
|
$85.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$51.3M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 71.13% |
| 2 | Financials | 3.44% |
| 3 | Technology | 0.52% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTLA
51
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $15M | 0.5% |
329,837
-244,709
| -43% | -$11.1M |
|
52
Pacira BioSciences
PCRX
$1.23B
| $15M | 0.5% |
+212,000
| New | +$15M |
|
53
Humana
HUM
$37.2B
| $14.4M | 0.48% |
75,500
-30,800
| -29% | -$5.89M |
|
54
Trupanion
TRUP
$1.93B
| $14.1M | 0.47% |
1,715,211
-386,637
| -18% | -$3.19M |
|
|
GEN
55
DELISTED
Genesis Healthcare, Inc.
GEN
| $14M | 0.47% |
2,119,616
+687,248
| +48% | +$4.54M |
|
|
AAC
56
DELISTED
AAC Holdings, Inc.
AAC
| $13.2M | 0.44% |
303,027
-143,301
| -32% | -$6.24M |
|
|
MRTX
57
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.5M | 0.42% |
397,660
+364,748
| +1,108% | +$11.5M |
|
58
Tonix Pharmaceuticals
TNXP
$244M
| $11.8M | 0.39% |
1,315,551
-49,449
| -4% | -$444K |
|
59
Axogen
AXGN
$715M
| $11.7M | 0.39% |
3,726,439
-144,385
| -4% | -$453K |
|
|
IMMU
60
DELISTED
Immunomedics Inc
IMMU
| $10.2M | 0.34% |
2,505,872
-100
| -0% | -$406 |
|
|
JUNO
61
DELISTED
Juno Therapeutics, Inc.
JUNO
| $9.77M | 0.33% |
183,149
| – | – |
|
|
FOMX
62
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $9.73M | 0.32% |
948,934
+269,307
| +40% | +$2.76M |
|
63
Astria Therapeutics
ATXS
$381M
| $9.01M | 0.3% |
+738,055
| New | +$9.01M |
|
|
ADYX
64
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $8.85M | 0.29% |
+1,679,111
| New | +$8.85M |
|
|
DERM
65
DELISTED
Dermira, Inc.
DERM
| $8.71M | 0.29% |
496,387
+264,920
| +114% | +$4.65M |
|
66
Pacific Biosciences
PACB
$384M
| $8.56M | 0.29% |
1,485,861
-1,562,449
| -51% | -$9M |
|
|
ATYR
67
aTyr Pharma
ATYR
$566M
| $8.55M | 0.28% |
+461,530
| New | +$8.55M |
|
68
Amphastar Pharmaceuticals
AMPH
$1.39B
| $7.89M | 0.26% |
448,532
| – | – |
|
|
STJ
69
DELISTED
St Jude Medical
STJ
| $7.87M | 0.26% |
107,719
+57,349
| +114% | +$4.19M |
|
|
OXFD
70
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.77M | 0.26% |
561,226
+38,976
| +7% | +$540K |
|
|
GNCA
71
DELISTED
Genocea Biosciences, Inc.
GNCA
| $7.75M | 0.26% |
564,257
-280,000
| -33% | -$3.84M |
|
72
Rigel Pharmaceuticals
RIGL
$695M
| $7.7M | 0.26% |
2,397,855
| – | – |
|
|
RLYP
73
DELISTED
RELYPSA INC COM
RLYP
| $7.45M | 0.25% |
+225,000
| New | +$7.45M |
|
74
Arcturus Therapeutics
ARCT
$465M
| $7.12M | 0.24% |
1,088,449
-324,759
| -23% | -$2.12M |
|
|
DSCI
75
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $6.94M | 0.23% |
968,881
-22,159
| -2% | -$159K |
|